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Extra-gastrointestinal stromal tumor (EGIST) is a special type of gas-
trointestinal stromal tumor, which has similar biological characteristics to
its counterpart, and occurs outside the gastrointestinal tract. It was iden-
tified first by Miettinen et al. [1], and named by Reith et al. [2]. The inci-
dence of EGIST is extremely low, and so far there is no detailed epidemi-
ological figure. To the best of our knowledge, EGIST has been commonly
reported in the mesentery, omentum or retroperitoneum [1-4], and spo-
radically in the pleura [5], pancreas [6-12], liver [13-17], gallbladder [18],
adrenal gland [19], bladder [20-22], prostate [23] and vagina [24, 25]. 
Most existing studies of EGIST are case reports, lacking enough informa-
tion to clarify the disease; thus it is very difficult to establish helpful guide-
lines for clinicians. It is very common that EGIST is misdiagnosed for oth-
er tumors. Herein, we report an extra-gastrointestinal stromal tumor of
the liver, which was diagnosed by ultrasound-guided fine needle aspira-
tion cytology (US-FNAC), and review the literature, so as to help under-
stand EGIST better. 
A 53-year-old Chinese man was admitted to the Affiliated Hospital of
Guangdong Medical College in July 2011 with the chief complaint of abdom-
inal discomfort in the right upper quadrant for 1 month. The patient denied
abdominal pain, diarrhea, nausea, vomiting, hematemesis, hematochezia,
fevers or chills. There was no loss of appetite or weight. He had an ultra-
sound scan three days previously in a local hospital, revealing a giant mass
in the liver. He had had sub-total gastrectomy because of gastric ulcer in
2005. 
Physical examination showed a well-developed man with abdominal
distention; yellow pigmented lesions, hepatic palm and spider angioma
were not seen; palpation indicated a large mass extending subcostally
approximately 18 cm, moderately tender and non-pulsatile; percussion
tenderness over hepatic region and shifting dullness were negative. 
Contrast-enhanced computerized tomography of the upper abdomen
was performed. It showed a giant irregular low-density mass almost occu-
pying the full right lobe of the liver; it was encircled by rich blood vessels,
and the maximum dimensions were about 17 cm × 20 cm; the pancreas
and right kidney were dislocated (Figure 1). Chest X-ray showed no abnor-
mal lesions. Tumor markers AFP, CA19-9 and CEA were all negative. Fecal
occult blood test was also negative. Both glutamate alanine aminotrans-
ferase and glutamic oxaloacetic transaminase were in the normal range.
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Figure 1. Contrast-enhanced computerized tomography. Contrast-enhanced CT shows a large mass about
17 cm × 20 cm almost occupying the full right lobe of the liver, which was encircled by rich blood vessels. The pan-
creas and right kidney were dislocated (A, B, C – transverse scan; D – coronal scan)
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Figure 2. Histological and immunohistochemical findings of hepatic EGIST. A – The tumor is composed of spindle
cells (hematoxylin and original magnification 200×). B – The spindle cells show pleomorphic nuclei, commonly vac-
uoles beside the nuclei and abundant intercellular collagen (hematoxylin and original magnification 400×). C – The
tumor cells test positive for SMA (original magnification 400×). D – Vimentin is diffusely and strongly positive in the
tumor cells (original magnification 400×)
A B
C D
Arch Med Sci 2, April / 2012 393394 Arch Med Sci 2, April / 2012
HBsAg, HBeAb and HBcAb were positive in second
liver two half-and-half tests. 
Due to the patient’s condition, hepatectomy
could not be performed, and a US-FNAB from the
liver mass was taken. Histologically the tumor con-
sisted of spindle cells with pleomorphic nuclei,
commonly vacuoles beside the nuclei and abun-
dant intercellular collagen (Figures 2 A-B). Immuno-
histochemical analysis revealed that the spindle
cells were positive for CD117 (Figure 3 B), CD34 (Fi-
gure 3 A), discovered on GIST1 (DOG-1) (focal) 
(Figure 3 D), SMA (Figure 2 C), and vimentin (Fi-
gure 2 D), while they were negative for CK (Figu-
re 3 C) and S-100 (figure not shown). All these
results indicated that the diagnosis was extra-gas-
trointestinal stromal tumor. The tumor’s mitotic
activity could not be evaluated because of the
small amount of examined material. KIT gene
mutation analysis was not performed due to its
non-availability at our institute. 
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Figure 3. Immunohistochemical findings of hepatic EGIST. A – CD34 positive in tumor cells (original magnification
400×). B – CD117 positive in tumor cells (original magnification 400×). C – CK negative in tumor cells (original mag-
nification 400×). D – DOG-1 focally positive in tumor cells (original magnification 400×)
A B
C D
Author, year Age  Gender Tumor  Cell type Mitosis/ CD117 CD34 Outcome
[years] size [cm] 50HPFa
Yamamoto 70 Male 20 Epithelioid 1 – + NAb
et al., 2010
Luo et al., 17 Male 5.1 Spindle NA +  + Alive  and
2009 well 3 months
Ochiai et al.,  30 Male > 10 Mixed 75 + + Alive and
2009 well 42 months
De Chiara et al., 37 Male 18 Spindle 20 + – Alive  and
2006 well 36 months
Hu et al., 2003 79 Female 15 Spindle 4/10HPF + + Recurrence 
16 months
The current study 53 Male 20 Spindle NA + + NA
aHPF – high-power field, bNA – not available
Table I. Hepatic EGIST reported in the literatureArch Med Sci 2, April / 2012 395
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We advised the patient to take imatinib mesy-
late (Glivec), but he refused because of financial
problems, and was discharged 13 days later.
Gastrointestinal stromal tumor (GIST) is a com-
mon tumor of the gastrointestinal tract, which
mainly occurs in the stomach. When this kind of
neoplasm develops outside the gastrointestinal
tract, it is defined as EGIST. Metastasis of GIST to
the liver is very common, while primary GIST of the
liver is extremely rare. To the best of our knowledge,
only 5 cases of primary hepatic EGIST have been
reported previously in English [13-17] (Table I). There
is a distinct male predominance, and their age
ranges from 17 to 79 years, average 47.7 years. The
majority have a large tumor size, only one under
10 cm. Four of 6 cases have a spindle cell type. Both
CD117 and CD34 have only one case that is nega-
tive. The mitotic rate and outcome are hard to ana-
lyze. Due to the particularity of hepatic EGIST, it
should be diagnosed differentially with primary or
metastatic poorly differentiated carcinoma,
angiomyolipoma, leiomyosarcoma, or malignant
melanoma. HMB-45 and PKCθ were recommended
in immunohistochemical analysis, so as to exclude
the mimics mentioned above [17]. 
US-FNAC is the quickest and least painful way
to obtain an accurate tissue diagnosis of a lump
anywhere in the body. There are three steps in 
US-FNAC: firstly, the position, size and adjacent
structure of the lesion are evaluated by ultrasound;
secondly, two or more samples are taken with a 23-
gauge or 25-gauge needle; lastly, the obtained sam-
ples are stained and examined by a pathologist. It
has multiple advantages compared to open biopsy,
which is not only inexpensive and minimally inva-
sive but is also performed simply and easily. Fur-
thermore, it allows surgery or neoadjuvant treat-
ment to be performed expeditiously with
a confirmed preoperative diagnosis. An accurate
diagnosis is made with the combination of clinical
examination, radiology and FNAC. Although EGIST
is rare, it also could be diagnosed by this technique.
Rao et al. [26] reported a case and reviewed three
cases of pancreatic EGIST, which were diagnosed
by US-FNAC. Luo et al. [15] showed that there was
no exception on hepatic EGIST. The present case
revealed that the biopsy samples were enough for
cytological analysis, although the mitotic rate could
not be determined.
In order to understand EGIST more clearly, we
have reviewed several quite large studies [1-4, 
27-30] (Table II) published recently. When these data
are summarized together, some similarities can be
seen distinctly. The incidence of EGIST is 5%-7% of
cases of GIST [4, 28], with a female predominance
(64.9%, 98/151), and the most frequent lesion sites
are the mesentery, omentum and retroperitoneum
[1-4]. The median age is 58.5 years, which is simi-396 Arch Med Sci 2, April / 2012
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lar to jejunal and ileal GISTs (59 years) [31]. Due to
EGIST being outside of the gastrointestinal tract,
there are no common symptoms such as bleeding
or obstruction. Furthermore, the abdominopelvic
cavity and retroperitoneum have enough room for
a neoplasm to grow. Thus most of the cases pre-
sented a tremendous mass when first detected,
with median size of 13.5 cm. Whether the tumor
size is a prognostic factor or not, it should be 
taken into account. Reith et al. [2] found that there
were no significant differences between large 
(> 10 cm) and small (≤ 10 cm) tumors in outcome.
The cell morphological pattern of EGIST is pre-
dominantly spindle (71 cases) or epithelioid (54 cas-
es). Three studies [1-3], in which the number of
patients was more than 20, were in accord with the
figure. Spindle cell EGIST should be diagnosed dif-
ferentially with smooth muscle tumors, schwanno-
ma, solitary fibrous tumor and sarcomatoid carci-
noma, while epithelioid EGIST should be diagnosed
differentially with metastatic melanoma, carcino-
ma, clear cell sarcoma and epithelioid heman-
gioendothelioma [32]. More than one third (55/135)
of cases displayed a mitotic index more than 5 per
high-power field (HPF). Yamamoto et al. [3] revealed
that a high mitotic rate (≥ 5/50 HPF) had signifi-
cantly shorter disease-specific survival than a low
rate (< 5/50 HPF) (p = 0.015). Almost 100% were
positive for CD117 [2-4, 29]. We think that it may be
because most of them are retrospective studies.
The patients were used to being easily misdiag-
nosed with other diseases. With this type of issue,
CD117 was recommended as a selection criterion.
CD117-negative tumors should be taken seriously;
it still cannot exclude EGIST. Demetri et al. [32] rec-
ommended using DOG-1 as a candidate when
CD117 immunostaining and mutation testing for KIT
and PDGFRA were all negative. About 57.1%
(84/147) of patients were CD34-positive, which was
lower than GIST (81%) [33]. Other antibody mark-
ers were different in these studies; thus it was hard
to analyze. Considering the follow-up data from dif-
ferent studies, it is very difficult to reach a persua-
sive conclusion. However, there is a trend that
EGIST is an aggressive group with worse outcome.
In conclusion, we have presented a case of
hepatic EGIST diagnosed by US-FNAC. The incidence
of EGIST is low, and it has a younger age of diag-
nosis and large tumor size. The mitotic index can
be a prognostic factor; however, tumor size still
needs more proof. Furthermore, EGIST can be mis-
diagnosed for other diseases, and clinicians should
take it seriously.
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